QTTB Latest Press Releases

-- July 14, 2026 --

Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants PRNewswire 10:59 PM

-- July 13, 2026 --

Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants PRNewswire 4:01 PM

Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata PRNewswire 6:59 AM

-- July 10, 2026 --

Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 PRNewswire 4:05 PM

-- May 27, 2026 --

Q32 Bio Announces $55 Million Private Placement Financing PRNewswire 8:00 AM

-- May 5, 2026 --

Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update PRNewswire 6:59 AM

-- April 8, 2026 --

Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference PRNewswire 6:59 AM

-- March 10, 2026 --

Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update PRNewswire 6:59 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software